Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
The paper outlines the author's experience on the efficacy and safety of androgen therapy of metabolic syndrome and obesity in men with hypogonadism. The study used testosterone undecanoate therapy that reduced body fat and the severity of the other components of the metabolic syndrome, improve...
Format: | Article |
---|---|
Language: | English |
Published: |
Endocrinology Research Centre
2013-03-01
|
Series: | Ожирение и метаболизм |
Subjects: | |
Online Access: | https://endojournals.ru/index.php/omet/article/view/5071 |
Similar Items
-
Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Published: (2012-12-01) -
Rol' korrektsii gipogonadizma v lecheniimetabolicheskogo sindroma u muzhchin i aspektybezopasnosti terapii preparatom testosteronaprolongirovannogo deystviya (rezul'tatydvoynogo slepogo randomizirovannogo platsebo-kontroliruemogo issledovaniya)
Published: (2010-06-01) -
Guidelines for the Diagnosis and Treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus
by: Ivan I. Dedov, et al.
Published: (2017-12-01) -
The role of hypogonadism correction in metabolic syndrome treatment in men: clinical case report
Published: (2009-06-01) -
Normogonadotropic hypogonadism in men with obesity
Published: (2009-09-01)